BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26391765)

  • 21. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
    Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
    Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.
    Furukawa Y; Tokuda E
    Adv Exp Med Biol; 2017; 925():1-12. PubMed ID: 27311318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
    Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
    Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular localization and RNAs determine FUS architecture in different cellular compartments.
    Yang L; Zhang J; Kamelgarn M; Niu C; Gal J; Gong W; Zhu H
    Hum Mol Genet; 2015 Sep; 24(18):5174-83. PubMed ID: 26123490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
    Basu S; Rajendra KC; Alagar S; Bahadur RP
    Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
    Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
    EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
    Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
    Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.
    Wang J; Ganaie SS; Cheng F; Xu P; Ning K; Wang X; Kleiboeker S; Cheng S; Qiu J
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered mRNP granule dynamics in FTLD pathogenesis.
    Bowden HA; Dormann D
    J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
    Bentmann E; Haass C; Dormann D
    FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
    Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
    Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study.
    Swetha RG; Ramaiah S; Anbarasu A
    J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FUS pathology in basophilic inclusion body disease.
    Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43.
    Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M
    PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.